Should you consider BANCO MACRO SA-ADR (NYSE:BMA) for growth investing?

In this article we will dive into BANCO MACRO SA-ADR (NYSE:BMA) as a possible candidate for growth investing. Investors should always do their own research, but we noticed BANCO MACRO SA-ADR showing up in our CANSLIM growth screen, which makes it worth to investigate a bit more.

Some of the canslim metrics of BMA highlighted

• With a favorable trend in its quarter-to-quarter (Q2Q) earnings per share (EPS), BMA highlights its ability to generate increasing profitability, showcasing a 1.0K% growth.
• BMA has demonstrated strong q2q revenue growth of 139.0%, suggesting a favorable trend in the company's financials and indicating the potential for continued expansion.
• The 3-year EPS growth of BMA (168.0%) highlights the company's ability to consistently improve its earnings performance and suggests a positive outlook for future profitability.
• With a favorable Return on Equity (ROE) of 28.16%, BMA demonstrates its ability to deliver attractive returns for shareholders. This metric highlights the company's effective management of assets and its profitability.
• BMA has achieved an impressive Relative Strength (RS) rating of 88.46, showcasing its ability to outperform the broader market.
• BMA exhibits a favorable Debt-to-Equity ratio at 0.13. This highlights the company's ability to limit excessive debt levels and maintain a strong equity base, demonstrating its financial stability and risk management practices.
• With institutional shareholders at 34.99%, BMA demonstrates a healthy ownership distribution. This reflects a mix of institutional and individual investors, creating a market environment that may foster increased trading activity and price discovery.

Analyzing the Technical Aspects

At ChartMill, a crucial aspect of their analysis is the assignment of a Technical Rating to each stock. This rating, ranging from 0 to 10, is calculated daily by considering numerous technical indicators and properties.

Overall BMA gets a technical rating of 4 out of 10. Although BMA is scoring some points because its good overall performance in the market in the past year, recent evolutions are not that positive. Both the medium and short term picture give negative signs.

• BMA is part of the Banks industry. There are 401 other stocks in this industry. BMA outperforms 82% of them.
• The long term trend is neutral, but the short term trend is negative. Better to stay away from this!
• Looking at the yearly performance, BMA did better than 88% of all other stocks. We also observe that the gains produced by BMA over the past year are nicely spread over this period. However, BMA's most recent performance is quite weak.
• BMA is currently trading in the middle of its 52 week range. This is in line with the S&P500 Index, which is also trading in the middle of its range.

Check the latest full technical report of BMA for a complete technical analysis.

How does the complete fundamental picture look for BMA?

ChartMill utilizes a proprietary algorithm to assign a Fundamental Rating to every stock. This rating, ranging from 0 to 10, is computed daily by analyzing a variety of fundamental indicators and properties.

Overall BMA gets a fundamental rating of 4 out of 10. We evaluated BMA against 401 industry peers in the Banks industry. BMA may be in some trouble as it scores bad on both profitability and health. BMA is valued quite expensively, but it does show have an excellent growth rating.

For an up to date full fundamental analysis you can check the fundamental report of BMA

More growth stocks can be found in our CANSLIM screen.

Disclaimer

This is not investing advice! The article highlights some of the observations at the time of writing, but you should always make your own analysis and invest based on your own insights.